Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from ALS ( (AU:ALQ) ) is now available.
In the 2025 financial year, ALS Limited achieved a 16% revenue growth to $3 billion, despite macroeconomic challenges, and maintained a strong operating margin of 19.1%. The company declared a final dividend of 19.7%, supported by a disciplined capital management strategy that included a $350 million equity raise to fund laboratory upgrades and future acquisitions. These investments aim to enhance capacity, efficiency, and market share, while maintaining flexibility and reducing environmental risks. ALS’s strategic focus on organic and inorganic growth positions it to benefit from industry trends and deliver sustainable, above-market growth.
The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$16.15 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.
More about ALS
ALS Limited is a global leader in the testing industry, providing independent, high-quality testing services across critical sectors such as mining, environmental compliance, food safety, and pharmaceutical regulation. The company is well-positioned to capitalize on long-term structural trends, including the shift toward outsourced testing and tightening regulatory standards.
Average Trading Volume: 1,189,162
Technical Sentiment Signal: Buy
Current Market Cap: A$9.15B
For a thorough assessment of ALQ stock, go to TipRanks’ Stock Analysis page.